Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02729597
Other study ID # DM-1-2
Secondary ID
Status Completed
Phase N/A
First received March 23, 2016
Last updated April 5, 2016
Start date May 2007
Est. completion date August 2015

Study information

Verified date April 2016
Source University Hospital, Bonn
Contact n/a
Is FDA regulated No
Health authority Germany: Ministry of Health
Study type Observational

Clinical Trial Summary

The natural history of brain affection in myotonic dystrophy types 1 and 2 is still unknown. The investigators designed a 5-year longitudinal neuropsychological and neuroimaging follow-up study to address this issue. Myotonic dystrophy type 1, myotonic dystrophy type 2 patients, and healthy controls were enrolled. All participants undergo clinical-neurological examinations, neuropsychological analyses according to a 13-item neuropsychological test battery, and 3T-brain MRI including voxel-based morphometry and diffusion tensor imaging at baseline and at follow-up using identical examination protocols.


Description:

It is unknown whether brain affection in myotonic dystrophy types 1 and 2 is due to neurodevelopmental defects, neurodegeneration, or both. An exact definition of the nature and dynamic of brain affection is of urgent need for the identification of clinical trial outcome parameters and the design of therapy compounds. The investigators planned a 5-year longitudinal study to examine the natural history of functional and structural brain affection. Myotonic dystrophy type 1, myotonic dystrophy type 2 patients, and healthy controls were enrolled. All participants undergo clinical-neurological examinations, neuropsychological analyses according to a 13-item neuropsychological test battery, and 3T-brain MRI at baseline and at follow-up using identical examination protocols. The intended time span between baseline and follow-up examinations is 5 years minimum. To investigate gray and white matter affection, voxel-based morphometry and diffusion tensor imaging are performed, and data are statistically analyzed including (i) group comparisons between patients and controls at baseline and follow-up, and (ii) group comparisons using difference maps to focus on isolated disease-related effects over time.


Recruitment information / eligibility

Status Completed
Enrollment 49
Est. completion date August 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 70 Years
Eligibility Inclusion criteria for healthy controls:

- written informed consent

- normal neurological examination without any acute or former neurological or severe psychiatric disease, no medical history of traumatic brain injury

Inclusion criteria for patients:

- written informed consent

- diagnosis confirmed by genetic testing

- no other neurological or severe psychiatric disease, no medical history of traumatic brain injury

Exclusion criteria for healthy controls and patients:

- use of psychoactive substances including alcohol (except nicotine), formerly or currently; treatment with modafinil

- severe psychiatric disorders, serious physical illnesses, particularly cardiovascular diseases, formerly or currently

- non-removable ferromagnetic metallic implants, sensors, stimulators, prostheses, pacemaker, large tattoos

- claustrophobia

- age under 18 years

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Intervention

Other:
medical history
The complete medical history (including cardiovascular risk factors and medication) will be assessed at baseline and follow-up.
neurological clinical examination
Neurological examination will be performed at baseline and follow-up.
neuropsychological testing
Neuropsychological testing using a 13 item test battery will be performed at baseline and follow-up.
brain MRI
Brain MRI ( 3.0 T) will be performed using the same hard- and software at baseline and follow-up.

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
University Hospital, Bonn Forschungszentrum Juelich, Life and Brain Center Bonn, The Marigold Foundation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in diffusivity indices as assessed by brain MRI with diffusion tensor imaging (DTI) sequences First analysis at baseline and after 5 years at follow-up No
Primary Gray matter changes assessed by magnetic resonance imaging (MRI)-voxel-based morphometry (VBM) First analysis at baseline and after 5 years at follow-up No
Primary Quantification of white matter lesions using age-related white matter changes (ARWMC) rating scale First analysis at baseline and after 5 years at follow-up No
Secondary MIRS (Muscular impairment rating scale) Rating scale to assess disease severity in myotonic dystrophy type 1 patients First analysis at baseline and after 5 years at follow-up No
Secondary Motor performance (Purdue Pegboard, bimanual) A bimanual task to assess fine motor function in patients and controls. Results are used as a covariate for neuropsychological tests First analysis at baseline and after 5 years at follow-up No
Secondary Beck Depression Inventory (BDI) To assess depressive symptoms First analysis at baseline and after 5 years at follow-up No
Secondary Boston Naming Test A test to evaluate semantic memory. First analysis at baseline and after 5 years at follow-up No
Secondary Verbal memory recognition task, a subtest of a computerised neuropsychological screening test battery, named NeuroCogFX (Fliessbach et al., 2006). Word list learning: 3 repetitions of word list presentation, 12 words. Yes/No recognition test (items:distractors 1 : 2) (reaction intervall: 2 seconds).
Data measurement: reaction time, number of correct hits
First analysis at baseline and after 5 years at follow-up No
Secondary Figural memory recognition task, a subtest of a computerised neuropsychological screening test battery, named NeuroCogFX (Fliessbach et al., 2006). Figural pattern learning: 12 different checkerboard patterns are presented, 3 repetitions of checkboard pattern presentation. Checkerboard consists of 3x3 fields, each pattern consists of 4 highlighted fields. Yes/No recognition test (items:distractors 1 : 2) (reaction interval: 2 seconds).
Data measurement: reaction time, number of correct hits
First analysis at baseline and after 5 years at follow-up No
Secondary Focussed Attention. Focussed attention concerning processing speed is assessed with a symbol-counting task (subtest 1 of the "Cerebraler Insuffizienztest", c.I.T.S. (Lehrl, 1997)). Data measurement: time First analysis at baseline and after 5 years at follow-up No
Secondary Psychomotoric Speed. Psychomotoric speed is assessed using the Trail-Making Test, TMT A (Reitan, 1958). The TMT-A test consists of 25 numbered circles randomly distributed over a sheet of paper. The study participant needs to draw lines to connect the numbers in ascending order.
Data measurement: time
First analysis at baseline and after 5 years at follow-up No
Secondary Reaction time, a subtest of a computerised neuropsychological screening test battery, named NeuroCogFX (Fliessbach et al., 2006). Data measurement: time First analysis at baseline and after 5 years at follow-up No
Secondary Selective attention (Choice reaction time), a subtest of a computerised neuropsychological screening test battery, named NeuroCogFX (Fliessbach et al., 2006). Data measurement: time First analysis at baseline and after 5 years at follow-up No
Secondary Interference. Interference is analysed using two tasks. Response inhibition subtest of the "Cerebraler Insuffizienztest" (c.I.T.I; Lehrl and Fischer, 1997).
Inverted choice reaction with reversed conditions of a choice reaction task, a subtest of a computerised neuropsychological screening test battery, named NeuroCogFX (Fliessbach et al., 2006).
Data measurement: reaction time
First analysis at baseline and after 5 years at follow-up No
Secondary Attention shift. Attentional shift is analysed using the the Trail-Making Test, TMT B (Reitan, 1958). The TMT B test consists of 25 circles randomly distributed over a sheet of paper. These circles include both numbers and letters. The study participant needs to draw lines to connect the numbers and letters in an ascending order, but alternating between numbers and letters.
Data measurement: time
First analysis at baseline and after 5 years at follow-up No
Secondary Visual-spatial / visual-constructive abilities. Visual-spatial / visual-constructive abilities are investigated using the Block design Test (part of "Hamburg-Wechsler Intelligenztest für Erwachsene"—Revision (HAWIE-R); Tewes, 1991). The block design test consists of 9 blocks and 9 pictures. The study participant needs to look at the picture and reconstruct each picture by arranging all 9 blocks.
Data measurement: time
First analysis at baseline and after 5 years at follow-up No
Secondary Phonematic fluency. Phonemic verbal word fluency is assessed using the oral word-fluency test, subtest 6 of the "Leistungsprüfsystem"; Horn, 1983. In a given time (one minute) the study participant needs to list as many words that begin with a certain letter.
Data measurement: number of correct words
First analysis at baseline and after 5 years at follow-up No
Secondary Semantic fluency. Semantic word fluency is assessed using a test by Strauss et al.,2006. A certain category is provided and in a given time (one minute) the study participant needs to list as many items belonging to that category.
Data measurement: number of correct items
First analysis at baseline and after 5 years at follow-up No
Secondary Daytime Sleepiness Scale (DSS) First analysis at baseline and after 5 years at follow-up No
Secondary Krupp's Fatigue Severity Scale (KFSS) First analysis at baseline and after 5 years at follow-up No
Secondary Epworth Sleepiness Scale (ESS) First analysis at baseline and after 5 years at follow-up No
Secondary Pittsburgh Sleep Quality Index (PSQI) First analysis at baseline and after 5 years at follow-up No
Secondary Ullanlinna-Narcolepsy Scale (UNS) First analysis at baseline and after 5 years at follow-up No
See also
  Status Clinical Trial Phase
Recruiting NCT02880735 - Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy N/A
Recruiting NCT06378216 - Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]
Active, not recruiting NCT06089018 - Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
Completed NCT05662150 - Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1 N/A
Active, not recruiting NCT04698551 - NIPD on cffDNA for Triplet Repeat Diseases
Completed NCT05027269 - Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients Phase 1/Phase 2
Completed NCT04712422 - Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1
Recruiting NCT05006924 - Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1
Recruiting NCT04656210 - Myotonic Dystrophy - Vascular and Cognition
Completed NCT04634682 - Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1 N/A
Withdrawn NCT06270186 - Evaluation of Cognitive Functions in 20 Patients With Type 1 Myotonic Dystrophy With Virtual Reality Approach N/A
Recruiting NCT06411288 - Global Study of Del-desiran for the Treatment of DM1 Phase 3
Recruiting NCT06300307 - Study of ATX-01 in Participants With DM1 Phase 1/Phase 2
Recruiting NCT06138743 - Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy Phase 1
Not yet recruiting NCT05532813 - Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease) Phase 3
Active, not recruiting NCT04886518 - Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 Phase 2
Completed NCT05036447 - Myotonic Dystrophy Type 1 and Resistance Exercise N/A
Recruiting NCT03424460 - Venous Thromboembolism in Myotonic Dystrophy Type 1 N/A
Recruiting NCT05865483 - Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)
Completed NCT04001920 - Effects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1 N/A